Bipolar depression: pharmacotherapy and related therapeutic strategies

@article{Thase2000BipolarDP,
  title={Bipolar depression: pharmacotherapy and related therapeutic strategies},
  author={Michael E. Thase and Gary S. Sachs},
  journal={Biological Psychiatry},
  year={2000},
  volume={48},
  pages={558-572}
}

Figures from this paper

The challenges of pharmacotherapy of bipolar depression
Pharmacotherapy of bipolar depression: An update
  • M. Thase
  • Psychology, Medicine
    Current psychiatry reports
  • 2006
TLDR
Conventional mood stabilizers are preferred for first-line therapies, although atypical antipsychotics are increasingly used, and FDA approval of quetiapine is pending.
Bipolar Depression: Issues in Diagnosis and Treatment
  • M. Thase
  • Psychology, Medicine
    Harvard review of psychiatry
  • 2005
TLDR
The optimal duration of maintenance antidepressant therapy has not been established empirically and, until better evidence‐based guidelines are established, should be determined on a case‐by‐case basis.
A review of acute treatments for bipolar depression
TLDR
The conclusion from this review is that a combination of an atypical antipsychotic and either an SSRI or lamotrigine may provide a useful first-line treatment for depressed bipolar disorder patients.
Bipolar Depression
TLDR
Recently, there has been a growing body of evidence suggesting that lamotrigine may have particular effectiveness in both the acute and prophylactic management of bipolar depression.
Advances in the pharmacologic treatment of bipolar depression
Bipolar depression: Diagnostic and treatment considerations
  • M. Thase
  • Psychology
    Development and Psychopathology
  • 2006
TLDR
Treatment with mood stabilizers, both conventional (i.e., lithium, valproate, and carbamazapine) and more recently classified and atypical antipsychotics should be prioritized, and several forms of focused psychotherapy may improve longer term outcomes.
What Drugs Are Best for Bipolar Depression?
TLDR
Current trends in the acute and long-term medication treatment of bipolar depression will be described, with particular focus on evidence from the existing literature.
Bupropion as Add-On Strategy in Difficult-to-Treat Bipolar Depressive Patients
TLDR
The data support the idea that bupropion is a first-line antidepressant in the treatment of severe bipolar depression, and co-medication with drugs commonly used in treatment-resistant bipolar disorder was safe in this small sample.
...
...

References

SHOWING 1-10 OF 162 REFERENCES
Treatment of Acute Bipolar Depression: A Review of the Literature
TLDR
It is recommended that mood stabilizers may be the first step of treatment, followed by the addition of an antidepressant, especially a cyclic antidepressant, in patients who are pharmacotherapy-resistant or psychotic.
Bupropion in the treatment of bipolar disorders: the same old story?
TLDR
It is suggested that buPropion may pose the same risks as other antidepressants in precipitating manic episodes in depressed bipolar patients and caution should be exercised when using bupropion in the treatment of bipolar disorders.
Treatment of depression in bipolar disorder: new directions for research.
TLDR
There are few studies of treatment of the depressed phase of bipolar disorder, and their results generally are limited or inconclusive, but limited data on other antidepressant classes suggest that monoamine oxidase inhibitors, bupropion, and serotonergic agents may offer some advantages over tricyclic antidepressants in this population.
Treatment-resistant bipolar depression.
  • G. Sachs
  • Psychology, Medicine
    The Psychiatric clinics of North America
  • 1996
Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
TLDR
Fluoxetine may be a safe and effective antidepressant monotherapy for the short-term treatment of BP II depression with a relatively low manic switch rate and may also be effective in relapse-prevention therapy in patients with BP II disorder.
Antidepressant treatment of the depressed patient with insomnia.
  • M. Thase
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 1999
TLDR
Early relief of insomnia in a depressed patient, in addition to alleviating other symptoms, may increase adherence to treatment and increase daytime performance and overall functioning, while complete relief ofomnia may improve prognosis.
A double- Blind placebo-controlled study of lamotriqine monotherapy outpatients with bipolar I depression
TLDR
Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar I depression and demonstrates significant antidepressant efficacy on the 17-item Hamilton Rating Scale for Depression and MADRS compared with placebo.
Bipolar disorder therapeutics: maintenance treatment
A double-blind trial of bupropion versus desipramine for bipolar depression.
TLDR
A prospective double-blind trial to assess efficacy and rate of treatment-emergent mood elevation in depressed bipolar patients when bupropion or desipramine was added to an ongoing therapeutic regimen of lithium or an anticonvulsant suggests that bupropions is less likely to induce mood elevation than desipramsine.
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
TLDR
Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression and demonstrates significant antidepressant efficacy on the 17-item Hamilton Rating Scale for Depression, MADRS, CGI-S, and CGI-I compared with placebo.
...
...